Prevalence and value of dissaving in the years prior to and after TB-treatment completion, stratified by wealth quintiles*
| Time period | Malawi urban wealth quintile (Q1–Q5)† | All participants | ||||
| Q1 (n=56) Wealthiest | Q2 (n=114) | Q3 (n=95) | Q4 (n=85) | Q5 (n=22) Poorest | ||
| Prior to TB illness (n=372) | ||||||
| Predisease monthly income (US$) | 108.30 (0–270.76) | 83.03 (39.71–287.73) | 63.18 (25.27–158.84) | 61.37 (25.27–111.91) | 41.52 (10.83–121.30) | 72.20 (25.27–173.29) |
| During TB illness and treatment (n=372) | ||||||
| Proportion incurring any dissaving | 28/56 (50.0%) | 83/114 (72.8%) | 75/95 (79.0%) | 68/85 (80.0%) | 20/22 (90.9%) | 274/372 (73.7%) |
| Value of dissaving, if experienced (US$)‡ | 166.9 (94.58–423.50) | 69.54 (34.77–173.85) | 38.94 (15.30–115.44) | 27.82 (16.69–80.95) | 33.38 (13.91–100.39) | 55.63 (20.86–139.08) |
| % of predisease monthly income (median, IQR) | 89.2% (34.1–266.0) | 58.2% (24.1–152.3) | 53.9% (20.7–111.2) | 41.6% (23.4–104.6) | 44.1% (35.0–173.4) | 54.9% (24.3–146.4) |
| Year after TB-treatment completion (n=360) | ||||||
| Proportion incurring any dissaving | 12/55 (21.8%) | 48/107 (44.9%) | 61/92 (66.3%) | 50/84 (59.5%) | 13/22 (59.1%) | 184/360 (51.1%) |
| Value of dissaving, if experienced (US$)‡ | 167.6 (59.36–272.35) | 69.83 (24.1–152.3) | 39.11 (20.95–92.18) | 37.71 (13.97–69.83) | 20.95 (11.17–31.42) | 41.9 (20.95–94.97) |
| % of predisease monthly income (median, IQR) | 112.5% (49.0–232.1) | 77.6% (19.0–198.7) | 59.3% (24.2–89.3) | 41.9% (13.6–120.7) | 29% (15.0–58.0) | 53.2% (19.0–125.7) |
*Values given for those who experienced dissaving, only.
†Baseline SES missing for 33 participants—data included for 372 participants only.
‡Standardisation into US$ using exchange rates at midpoints of first and last study visits.
SES, socioeconomic situation; TB, tuberculosis.